Espero Pharmaceuticals announced that the Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for GoNitro (nitroglycerin) for acute relief of an attack or ...

GoNitro Espero announced the launch of GoNitro (nitroglycerin) sublingual powder for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease. Espero announced the ...

What is nitroglycerin used for? Nitroglycerin is commonly used to treat and prevent chest pain caused by a type of heart disease (coronary artery disease). Nitroglycerin may also be used for other ...

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Espero Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved ...

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Espero Pharmaceuticals Inc., a privately held specialty pharmaceutical company, today announced the commercial availability of GONITRO™ (nitroglycerin) sublingual ...